- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 198 results
Webinar
декабря 11, 2023
#Sponsored: Influencer Marketing 201 for Pharmaceutical and Medical Device Companies
Webinar
ноября 30, 2023
FDA’s Latest Salvo in the LDT (Laboratory Developed Tests) Wars
Webinar
ноября 15, 2023
FDA’s PDURS Guidance: Questions Asked and (Not) Answered
Webinar
ноября 14, 2023
What You Need to Know Now to Protect and Improve Commercial Managed Care Revenue
Webinar
октября 31, 2023
How to Launch a Telehealth Clinic: Legal Considerations
Webinar
октября 26, 2023
Navigating the Foreign Agents Registration Act (FARA): Where is DOJ Headed?
Webinar
октября 26, 2023
An Update on No Surprises Act Implementation and Developments on the Hospital Price Transparency Rule
Webinar
октября 10, 2023
Key Food and Beverage Issues: Recent Developments in False Advertising Litigation in the U.S and the European Union
Webinar
сентября 27, 2023
At Last! FDA Issues Final Guidance on Use of Real-World Evidence for Regulatory Decision-Making for Drug and Biological Products
Webinar
сентября 19, 2023
2023 IPPS Final Rule: Analysis and Opportunity
Webinar
августа 29, 2023
Investigations & Enforcement Developments for Life Sciences and Healthcare Companies